Diet supplementation with beta-carotene improves the serum lipid profile in rats fed a cholesterol-enriched diet. 2013

Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
Research Center in Biological Sciences (NUPEB), Federal University of Ouro Preto, Ouro Preto, Minas Gerais, Brazil, lohrehna@yahoo.com.br.

The present study investigated the underlying mechanism associated with the hypocholesterolemic activity of beta-carotene by examining its effects on the serum lipid profile, fecal cholesterol excretion, and gene expression of the major receptors, enzymes, and transporters involved in cholesterol metabolism. Female Fischer rats were divided into three groups and were fed either a control or a hypercholesterolemic diet supplemented or not supplemented with 0.2 % beta-carotene. After 6 weeks of feeding, blood, livers, and feces were collected for analysis, and quantitative real-time polymerase chain reaction (qRT-PCR) was performed. Dietary supplementation with 0.2 % beta-carotene decreased serum total cholesterol, non-HDL cholesterol, the atherogenic index, and hepatic total lipid and cholesterol contents. These changes were accompanied by an increase in the total lipid and cholesterol contents excreted in the feces. The qRT-PCR analyses demonstrated that the hypercholesterolemic diet promoted a decrease in the gene expression of sterol regulatory element-binding protein 2, 3-hydroxy-3-methylglutaryl CoA reductase, and low-density lipoprotein receptor and an increase in the gene expression of peroxisome proliferator-activated receptor α and cholesterol-7a-hydroxylase. The expression of these genes and gene expression of ATP-binding cassette subfamily G transporters 5and 8 were unaffected by beta-carotene supplementation. In conclusion, the decrease in serum cholesterol and the elevation of fecal cholesterol obtained following beta-carotene administration indicate that this substance may decrease cholesterol absorption in the intestine and increase cholesterol excretion into the feces without a direct effect on the expression of cholesterol metabolism genes.

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002790 Cholesterol 7-alpha-Hydroxylase A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS. CYP7,CYP7A,Cytochrome P-450 CYP7,CYP 7,CYP 7A,Cholesterol 7-alpha-Monooxygenase,Cholesterol 7alpha-Hydroxylase,Cholesterol-7-Hydroxylase,Cytochrome P450 7,Cholesterol 7 Hydroxylase,Cholesterol 7 alpha Hydroxylase,Cholesterol 7 alpha Monooxygenase,Cholesterol 7alpha Hydroxylase,Cytochrome P 450 CYP7
D002791 Cholesterol, Dietary Cholesterol present in food, especially in animal products. Dietary Cholesterol
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006903 Hydroxymethylglutaryl CoA Reductases Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-hydroxy-3-methylglutaryl-coenzyme A to yield MEVALONIC ACID. HMG CoA Reductases,3-Hydroxy-3-methylglutaryl CoA Reductase,HMG CoA Reductase,Hydroxymethylglutaryl CoA Reductase,3 Hydroxy 3 methylglutaryl CoA Reductase,CoA Reductase, 3-Hydroxy-3-methylglutaryl,Reductase, 3-Hydroxy-3-methylglutaryl CoA
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol

Related Publications

Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
September 1992, The Journal of nutrition,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
October 2015, Phytotherapy research : PTR,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
October 2015, BMC complementary and alternative medicine,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
March 2011, Journal of physiology and biochemistry,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
December 2009, The British journal of nutrition,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
January 2016, Food & nutrition research,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
October 2022, Heliyon,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
October 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
January 2016, Journal of nutritional science and vitaminology,
Lorena Souza E Silva, and Aline Mayrink de Miranda, and Cíntia Lopes de Brito Magalhães, and Rinaldo Cardoso Dos Santos, and Maria Lúcia Pedrosa, and Marcelo Eustáquio Silva
October 2002, Journal of nutritional science and vitaminology,
Copied contents to your clipboard!